A recent study described the increased mortality of sepsis patients with high levels of circulating OLFM4+ neutrophils and the same was true for non-septic patients with infections and Systemic Inflammatory Response Syndrome (SIRS). This evidence concerns the gene OLFM4 and systemic inflammatory response syndrome.